Vaccination

Glenmark announces 400 mg 'FabiFlu' for Covid-19 treatment

Glenmark Pharmaceuticals, a research-led global pharmaceutical company, on Thursday announced that it is set to introduce a 400 mg version of oral antiviral - FabiFlu -- for the treatment of mild to moderate Covid-19 in India. Aug 7, 2020
Home Quarantine Heroes

Buddy Volunteers in Bengaluru are helping make COVID home isolation easier

In the time of COVID-19, it's become hard on everybody to keep the faith. With many patients under home isolation, they would all require some support, especially in times of need and emergency. Here's how a group of home volunteers are reaching out to those in home quarantine, showing us that a sense of humanity is still quite thriving. Aug 3, 2020